DE3779032D1 - Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia-viren, die sich in cho-zellen vermehren koennen. - Google Patents

Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia-viren, die sich in cho-zellen vermehren koennen.

Info

Publication number
DE3779032D1
DE3779032D1 DE8787402104T DE3779032T DE3779032D1 DE 3779032 D1 DE3779032 D1 DE 3779032D1 DE 8787402104 T DE8787402104 T DE 8787402104T DE 3779032 T DE3779032 T DE 3779032T DE 3779032 D1 DE3779032 D1 DE 3779032D1
Authority
DE
Germany
Prior art keywords
recombinant
viruses
cho cells
vectors
dna sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8787402104T
Other languages
English (en)
Inventor
Robert Drillien
Daniele Spehner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Transgene SA
Original Assignee
Transgene SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Transgene SA filed Critical Transgene SA
Application granted granted Critical
Publication of DE3779032D1 publication Critical patent/DE3779032D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE8787402104T 1986-09-23 1987-09-21 Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia-viren, die sich in cho-zellen vermehren koennen. Expired - Fee Related DE3779032D1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8613272A FR2604183B1 (fr) 1986-09-23 1986-09-23 Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho

Publications (1)

Publication Number Publication Date
DE3779032D1 true DE3779032D1 (de) 1992-06-17

Family

ID=9339184

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8787402104T Expired - Fee Related DE3779032D1 (de) 1986-09-23 1987-09-21 Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia-viren, die sich in cho-zellen vermehren koennen.

Country Status (9)

Country Link
US (1) US5830688A (de)
EP (1) EP0262043B1 (de)
JP (2) JP2683804B2 (de)
AT (1) ATE76099T1 (de)
AU (1) AU598859B2 (de)
CA (1) CA1341242C (de)
DE (1) DE3779032D1 (de)
DK (1) DK498387A (de)
FR (1) FR2604183B1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364773A (en) * 1991-03-07 1994-11-15 Virogenetics Corporation Genetically engineered vaccine strain
US7767449B1 (en) 1981-12-24 2010-08-03 Health Research Incorporated Methods using modified vaccinia virus
US5833975A (en) * 1989-03-08 1998-11-10 Virogenetics Corporation Canarypox virus expressing cytokine and/or tumor-associated antigen DNA sequence
WO1989012103A1 (en) * 1988-06-10 1989-12-14 Applied Biotechnology, Inc. Method of selecting for recombinant pox viruses
WO1990010693A1 (en) * 1989-03-08 1990-09-20 Health Research, Inc. Recombinant poxvirus host selection system
US5225336A (en) * 1989-03-08 1993-07-06 Health Research Incorporated Recombinant poxvirus host range selection system
US6514502B1 (en) 1999-01-26 2003-02-04 Schering-Plough Veterinary Corporation Propagation of bovine cononavirus in chinese hamster ovary cells
SG11201603919XA (en) * 2013-11-01 2016-07-28 Sementis Ltd Viral vector manufacture
WO2024003346A1 (en) 2022-06-30 2024-01-04 Bavarian Nordic A/S Mammalian cell line for the production of modified vaccinia virus ankara (mva)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4769330A (en) * 1981-12-24 1988-09-06 Health Research, Incorporated Modified vaccinia virus and methods for making and using the same
WO1984002077A1 (en) * 1982-11-30 1984-06-07 Us Health Process for producing poxvirus recombinants for expression of foreign genes
WO1985005376A1 (fr) * 1984-05-22 1985-12-05 Transgene S.A. Vecteurs d'expression du facteur ix et lignees cellulaires produisant le facteur ix actif

Also Published As

Publication number Publication date
ATE76099T1 (de) 1992-05-15
US5830688A (en) 1998-11-03
DK498387D0 (da) 1987-09-22
FR2604183B1 (fr) 1988-12-30
JPH09206084A (ja) 1997-08-12
AU598859B2 (en) 1990-07-05
JP2683804B2 (ja) 1997-12-03
FR2604183A1 (fr) 1988-03-25
EP0262043A1 (de) 1988-03-30
EP0262043B1 (de) 1992-05-13
DK498387A (da) 1988-03-24
AU7890687A (en) 1988-05-19
JPS63157988A (ja) 1988-06-30
JP2818836B2 (ja) 1998-10-30
CA1341242C (fr) 2001-06-05

Similar Documents

Publication Publication Date Title
PT76546A (en) Process for preparing functional human urokinase protein
ATE97164T1 (de) Rekombinantes vaccinia-virus mva.
KR870007282A (ko) 효모에서 b형 간염 바이러스 단백질을 제조하는 방법
DK0935660T3 (da) Infektiöse kloner af RNA-virusser og vacciner og deraf afledte diagnostiske assays
AU580059B2 (en) Vaccine against rabies and preparation process thereof
DE3773963D1 (de) Verfahren zur herstellung von reifem, menschlichem serum-albumin.
ES545725A0 (es) Procedimiento para preparar peptidos de interferon
DE3779032D1 (de) Dns-sequenz, vektoren, rekombinante viren und verfahren zur verwendung rekombinanter vaccinia-viren, die sich in cho-zellen vermehren koennen.
PT73021A (en) Process for producing dna sequences of recombinant dna molecules and polipeptides with specificyty on foot mouth disease as viral antigens
DE3582203D1 (de) Dns-sequenzen, rekombinante dns und verfahren zur herstellung von plasmodium-falciparum-antigenen.
DE3585578D1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
ES2100185T3 (es) Secuencia de adnc y deteccion del virus de la hepatitis c.
DE3789525D1 (de) Das F-Protein vom AIDS-Virus enthaltender Impfstoff.
DE3787121D1 (de) Verfahren zur Herstellung und Verwendung von Katzenleukämievirus-Antigenen.
ATE31733T1 (de) Verfahren zur herstellung von hybridisierungssonden.
DE3770086D1 (de) Verfahren zur herstellung von 2,2-bis(4'-hydroxyphenyl)-propanen.
DK0414035T3 (da) Gibbonabe-leukæmi-virusreceptor
ZA813110B (en) Dna sequences, recombinant dna molecules and processes for producing polypedtides with the specificity of foot and mouth disease viral antigens

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee